Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
715 | 3069 | 48.1 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2038 | 4889 | RESVERATROL//TRANS RESVERATROL//PTEROSTILBENE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RESVERATROL | Author keyword | 1075 | 46% | 57% | 1754 |
2 | PTEROSTILBENE | Author keyword | 77 | 61% | 3% | 81 |
3 | PICEATANNOL | Author keyword | 34 | 42% | 2% | 61 |
4 | TRANS RESVERATROL | Author keyword | 26 | 30% | 2% | 73 |
5 | RESVERATROL ANALOGUES | Author keyword | 26 | 80% | 1% | 16 |
6 | RESVERATROL DERIVATIVES | Author keyword | 15 | 67% | 0% | 14 |
7 | DIHYDRORESVERATROL | Author keyword | 12 | 86% | 0% | 6 |
8 | PINOSYLVIN | Author keyword | 8 | 40% | 1% | 16 |
9 | DMU 212 | Author keyword | 8 | 100% | 0% | 5 |
10 | RESVERATROL METABOLITES | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RESVERATROL | 1075 | 46% | 57% | 1754 | Search RESVERATROL | Search RESVERATROL |
2 | PTEROSTILBENE | 77 | 61% | 3% | 81 | Search PTEROSTILBENE | Search PTEROSTILBENE |
3 | PICEATANNOL | 34 | 42% | 2% | 61 | Search PICEATANNOL | Search PICEATANNOL |
4 | TRANS RESVERATROL | 26 | 30% | 2% | 73 | Search TRANS+RESVERATROL | Search TRANS+RESVERATROL |
5 | RESVERATROL ANALOGUES | 26 | 80% | 1% | 16 | Search RESVERATROL+ANALOGUES | Search RESVERATROL+ANALOGUES |
6 | RESVERATROL DERIVATIVES | 15 | 67% | 0% | 14 | Search RESVERATROL+DERIVATIVES | Search RESVERATROL+DERIVATIVES |
7 | DIHYDRORESVERATROL | 12 | 86% | 0% | 6 | Search DIHYDRORESVERATROL | Search DIHYDRORESVERATROL |
8 | PINOSYLVIN | 8 | 40% | 1% | 16 | Search PINOSYLVIN | Search PINOSYLVIN |
9 | DMU 212 | 8 | 100% | 0% | 5 | Search DMU+212 | Search DMU+212 |
10 | RESVERATROL METABOLITES | 8 | 100% | 0% | 5 | Search RESVERATROL+METABOLITES | Search RESVERATROL+METABOLITES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TRANS RESVERATROL | 420 | 51% | 19% | 595 |
2 | CHEMOPREVENTIVE AGENT RESVERATROL | 158 | 75% | 4% | 114 |
3 | RED WINE | 108 | 19% | 17% | 522 |
4 | CANCER CHEMOPREVENTIVE AGENT | 76 | 70% | 2% | 63 |
5 | NATURAL POLYPHENOLIC COMPOUND | 56 | 85% | 1% | 29 |
6 | LOW BIOAVAILABILITY | 52 | 75% | 1% | 38 |
7 | NATURAL PRODUCT PRESENT | 47 | 81% | 1% | 29 |
8 | DIETARY RESVERATROL | 41 | 100% | 0% | 15 |
9 | WINE POLYPHENOL RESVERATROL | 38 | 93% | 0% | 14 |
10 | POLYPHENOLIC COMPOUND | 37 | 67% | 1% | 33 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Resveratrol supplementation: Where are we now and where should we go? | 2015 | 7 | 138 | 75% |
Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans | 2014 | 29 | 60 | 95% |
The molecular targets of resveratrol | 2015 | 12 | 127 | 35% |
Therapeutic potential of resveratrol: the in vivo evidence | 2006 | 1474 | 216 | 51% |
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases | 2015 | 5 | 296 | 62% |
Resveratrol and cancer: Challenges for clinical translation | 2015 | 4 | 52 | 67% |
Resveratrol and cancer: focus on in vivo evidence | 2014 | 23 | 129 | 66% |
Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies | 2004 | 677 | 332 | 68% |
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials | 2009 | 160 | 72 | 89% |
Resveratrol: A review of preclinical studies for human cancer prevention | 2007 | 298 | 103 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NUTR OBES GRP | 8 | 50% | 0.4% | 11 |
2 | ANAT COMPARED PATHOL | 6 | 80% | 0.1% | 4 |
3 | FISIOL FARM | 6 | 71% | 0.2% | 5 |
4 | EA ST S CELLULAIRE PHYSIOPATHOL STRATEGIES NUTR | 6 | 100% | 0.1% | 4 |
5 | BIOCHEM METAB NUTR | 4 | 75% | 0.1% | 3 |
6 | CLIN PHARM DIAGNOST | 4 | 14% | 0.8% | 26 |
7 | RECERCA NUTR SEGURETAT ALIMENTARIA INSA UB | 3 | 45% | 0.2% | 5 |
8 | LIAONING CANC GENOM | 3 | 38% | 0.2% | 6 |
9 | UR ETHNOBOT ST S OXYDANT | 3 | 60% | 0.1% | 3 |
10 | CANC CHEMOPREVENT GRP | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000252248 | PICEID//POLYDATIN//TRANS RESVERATROL |
2 | 0.0000094382 | GNETACEAE//OLIGOSTILBENE//RESVERATROL OLIGOMER |
3 | 0.0000081488 | SIRT1//SIRTUIN//SIRT3 |
4 | 0.0000061161 | GRAPE SEED EXTRACT//GRAPE SEED PROANTHOCYANIDINS//GRAPE SEED PROANTHOCYANIDIN EXTRACTS |
5 | 0.0000048269 | RED WINE//RED WINE POLYPHENOLS//DLSPH |
6 | 0.0000048018 | ENDOGENOUS COPPER//PROOXIDANT ACTION//CUII REDUCTION |
7 | 0.0000040978 | MIR 1260B//NOUVEL HOP ESTAING//DIETARY COMPOUNDS |
8 | 0.0000034842 | C7ORF24//GAMMA GLUTAMYL CYCLOTRANSFERASE//HEPATITIS C VIRUS ASSOCIATED LIVER CIRRHOSIS |
9 | 0.0000034242 | QUERCETIN//QUERCETIN METABOLITES//QUERCETIN CONJUGATES |
10 | 0.0000032176 | DEOXYBENZOINS//BIOMOLEC FUNCT//DEOXYBENZOIN DERIVATIVES |